66

RCMIX MODEL BASED ON PRE-NEOADJUVANT THERAPY T2WI IMAGING CAN PREDICT THE T-STAGE DOWNSTAGING IN MRI-CT4 STAGE RECTAL CANCER PATIENTS

Date
May 18, 2024

Abstract
Objective:
To develop an effective machine learning model to predicts T-stage downstaging in MRI-cT4 stage rectal cancer (RC) patients before neoadjuvant therapy.
Materials and Methods:
Data from 136 MRI-T4 RC patients (96 males [70.6%]; mean age ± standard deviation, 54.7±12.3 years) were randomly divided into the training (n = 108) and test cohort (n = 28) with a ratio of 8:2. Based on the comparison between MRI-T grade before neoadjuvant therapy and pathological-T grade, patients were divided into Well T-downstage (cT4 to ypT≤2) and Poor T-downstage (cT4 to ypT≥3) groups. A total of 1834 radiomics features were extracted from T2-weighted imaging (T2WI) images. The least absolute shrinkage and selection operator (LASSO) regression method was applicated to select features. k-Nearest Neighbor (k-NN) was applicated to construct radiomics and clinical models. Finally, a model called RCMix that combined clinical with radiomics features was developed. The RCMix model was evaluated by receiver operating characteristic (ROC) curve and decision curve.
Results:
RCMix model was developed by CEA, CA19-9, and 14 radiomic features. The area under the ROC curve (AUC) of the RCMix model was 0.918 (95 % confidence interval, 0.868–0.967) in the training cohort and 0.836 (0.669–1.000) in the test cohort. The AUC of the radiomics model was 0.746 (0.656–0.837) in the training cohort and 0.813 (0.669–0.957) in the test cohort. The AUC of the clinical model was 0.847 (0.780–0.914) in the training cohort and 0.778 (0.593–0.962) in the test cohort. The AUC of the RCMix model was significantly larger than that of the clinical model (p = 0.049). The decision curve analysis indicated its clinical usefulness.
Conclusion:
The RCMix model achieved satisfactory performance in predicting T-stage downstaging in MRI-cT4 RC patients, accurately stratifying this group prior to receiving neoadjuvant therapy.

Tracks

Related Products

Thumbnail for ROBOTIC TRANSGASTRIC PANCREATIC NECROSECTOMY: SINGLE STAGE PROCEDURE FOR WALLED-OFF PANCREATIC NECROSIS
ROBOTIC TRANSGASTRIC PANCREATIC NECROSECTOMY: SINGLE STAGE PROCEDURE FOR WALLED-OFF PANCREATIC NECROSIS
45 yo M with walled off pancreatic necrosis who underwent robotic cystogastrostomy and transgastric pancratic necrosectomy. CT scan demonstrated necrosis confined to the lesser sac. A step-up approach was unsuccessful. Robotic debridement was offered…
Thumbnail for Colorectal Diseases I
Colorectal Diseases I
ELEVATED RED CELL DISTRIBUTION WIDTH TO PLATELET RATIO IS ASSOCIATED WITH LOW GRADE DYSPLASIA IN IBD
Thumbnail for ROBOTIC ANATOMICAL RIGHT HEPATECTOMY FOR NECROTIC CHOLANGIOCARCINOMA
TECHNIQUE OF INFLOW CONTROL IN NAKAMURA TYPE B PORTAL VEIN ANATOMY
ROBOTIC ANATOMICAL RIGHT HEPATECTOMY FOR NECROTIC CHOLANGIOCARCINOMA TECHNIQUE OF INFLOW CONTROL IN NAKAMURA TYPE B PORTAL VEIN ANATOMY
Anatomical variations in the inflow vasculatures must be anticipated in any anatomical hepatectomy to avoid complications. Nakamura Type B portal vein (PV) anatomy requires individual isolation of right anterior and posterior PV to avoid narrowing of the left PV…
Thumbnail for LAPAROSCOPIC TOTAL PANCREATECTOMY AFTER LAPAROSCOPIC WHIPPLE FOR PANCREATIC DUCTAL ADENOCARCINOMA
LAPAROSCOPIC TOTAL PANCREATECTOMY AFTER LAPAROSCOPIC WHIPPLE FOR PANCREATIC DUCTAL ADENOCARCINOMA
Improvements in systemic therapy may increase rate of 2nd novo PDAC after prior PDAC